|
1
|
Luo F, Yu L, Xian X, Shan B, Das A. Editorial: New and emerging lipid-lowering therapies for reducing cardiovascular risk: beyond statins. Front Cardiovasc Med 2024; 11:1364170. [PMID: 38287985 PMCID: PMC10822986 DOI: 10.3389/fcvm.2024.1364170] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/01/2024] [Accepted: 01/08/2024] [Indexed: 01/31/2024] Open
Affiliation(s)
- Fei Luo
- Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China
| | - Liqing Yu
- School of Medicine, University of Maryland, Baltimore, MD, United States
| | - Xunde Xian
- Institute of Cardiovascular Sciences and Key Laboratory of Molecular Cardiovascular Sciences, Ministry of Education, Peking University, Beijing, China
| | - Bo Shan
- Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China
| | - Avash Das
- Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States
| |
Collapse
|